| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF449 ZNF793 ZNF671 ZSCAN12 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 INSM1 OSR2 NR4A3 NR4A1 ZNF467 ZFP69 ZNF865 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF518A ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 2.70e-29 | 1459 | 127 | 55 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF449 ZNF793 ZSCAN12 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 INSM1 OSR2 NR4A3 NR4A1 ZNF467 ZFP69 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF518A ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 ZNF100 ZNF394 ZNF334 ZNF43 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 5.09e-27 | 1412 | 127 | 52 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF449 ZNF793 ZNF671 ZSCAN12 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF460 PATZ1 ZFP30 INSM1 NR4A3 NR4A1 ZNF467 ZNF865 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF546 ZNF585B ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF182 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF655 ZNF540 ZNF347 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 1.10e-23 | 1244 | 127 | 46 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF449 ZNF793 ZNF671 ZSCAN12 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF460 PATZ1 ZFP30 INSM1 NR4A3 NR4A1 ZNF467 ZNF865 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF546 ZNF585B ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF182 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF655 ZNF540 ZNF347 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 2.69e-23 | 1271 | 127 | 46 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF585A ZBTB17 PATZ1 OSR2 NR4A3 NR4A1 ZNF467 ZNF850 ZNF786 ZNF585B ZNF594 ZNF43 ZNF624 ZNF841 ZNF319 ZFP62 | 5.46e-07 | 560 | 127 | 16 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF585A ZBTB17 PATZ1 OSR2 NR4A3 NR4A1 ZNF467 ZNF850 ZNF786 ZNF585B ZNF594 ZNF43 ZNF624 ZNF841 ZNF319 ZFP62 | 6.28e-07 | 566 | 127 | 16 | GO:0001216 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 2.49e-06 | 5 | 127 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.02e-03 | 120 | 127 | 5 | GO:0004222 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF585A ZBTB17 NTF3 PATZ1 OSR2 NR4A3 TLR7 NR4A1 ZNF467 ZNF850 ZNF786 ZNF585B KMT2C ZNF594 ABLIM1 PRDM9 MBTPS2 ZNF43 ZNF841 TNFRSF1A ZNF319 ZFP62 | 3.37e-05 | 1390 | 126 | 22 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 3.70e-05 | 2 | 126 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 6.72e-05 | 36 | 126 | 4 | GO:0007274 | |
| GeneOntologyCellularComponent | spine apparatus membrane | 1.08e-04 | 3 | 126 | 2 | GO:0098897 | |
| MousePheno | airway basal cell hyperplasia | 3.40e-05 | 2 | 82 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 3.40e-05 | 2 | 82 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 3.40e-05 | 2 | 82 | 2 | MP:0011113 | |
| Domain | zf-C2H2 | ZNF449 ZNF793 ZNF671 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 INSM1 OSR2 ZNF467 ZFP69 ZNF865 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF518A ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF45 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 1.03e-43 | 693 | 126 | 54 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF449 ZNF793 ZNF671 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 INSM1 OSR2 ZNF467 ZFP69 ZNF865 ZNF850 ZKSCAN5 ZNF786 ZNF587B ZNF518A ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF45 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 2.31e-42 | 694 | 126 | 53 | IPR013087 |
| Domain | - | ZNF449 ZNF793 ZNF671 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 INSM1 OSR2 ZNF467 ZFP69 ZNF865 ZNF850 ZKSCAN5 ZNF786 ZNF587B ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF45 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 1.51e-41 | 679 | 126 | 52 | 3.30.160.60 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF449 ZNF793 ZNF671 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 INSM1 OSR2 ZNF467 ZFP69 ZNF865 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF518A ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF45 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 3.94e-41 | 775 | 126 | 54 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF449 ZNF793 ZNF671 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 INSM1 OSR2 ZNF467 ZFP69 ZNF865 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF518A ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF45 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 4.51e-41 | 777 | 126 | 54 | PS00028 |
| Domain | Znf_C2H2 | ZNF449 ZNF793 ZNF671 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 INSM1 OSR2 ZNF467 ZFP69 ZNF865 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF518A ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF45 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 2.92e-40 | 805 | 126 | 54 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF449 ZNF793 ZNF671 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 INSM1 OSR2 ZNF467 ZFP69 ZNF865 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF518A ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF45 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 3.56e-40 | 808 | 126 | 54 | SM00355 |
| Domain | Znf_C2H2-like | ZNF449 ZNF793 ZNF671 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 INSM1 OSR2 ZNF467 ZFP69 ZNF865 ZNF850 ZKSCAN5 ZNF786 ZNF587B ZNF518A ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF45 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 2.87e-39 | 796 | 126 | 53 | IPR015880 |
| Domain | KRAB | ZNF793 ZNF671 ZNF585A ZNF354A ZNF154 ZNF337 ZNF460 ZFP30 ZFP69 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF334 ZNF43 ZNF45 ZNF540 ZNF347 ZNF624 ZNF480 ZNF431 ZNF420 ZNF30 ZNF583 | 5.19e-31 | 358 | 126 | 35 | PF01352 |
| Domain | KRAB | ZNF793 ZNF671 ZNF585A ZNF354A ZNF154 ZNF337 ZNF460 ZFP30 ZFP69 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF334 ZNF43 ZNF45 ZNF540 ZNF347 ZNF624 ZNF480 ZNF431 ZNF420 ZNF30 ZNF583 | 1.50e-30 | 369 | 126 | 35 | SM00349 |
| Domain | KRAB | ZNF793 ZNF671 ZNF585A ZNF354A ZNF154 ZNF337 ZNF460 ZFP30 ZFP69 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF334 ZNF43 ZNF45 ZNF540 ZNF347 ZNF624 ZNF480 ZNF431 ZNF420 ZNF30 ZNF583 | 1.64e-30 | 370 | 126 | 35 | IPR001909 |
| Domain | KRAB | ZNF793 ZNF671 ZNF585A ZNF354A ZNF154 ZNF337 ZNF460 ZFP30 ZFP69 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 ZNF20 ZNF182 ZNF100 ZNF394 ZNF334 ZNF43 ZNF45 ZNF540 ZNF347 ZNF624 ZNF480 ZNF431 ZNF420 ZNF30 ZNF583 | 1.11e-29 | 358 | 126 | 34 | PS50805 |
| Domain | zf-C2H2_6 | ZNF449 ZNF671 ZNF354A ZNF154 PATZ1 ZFP30 OSR2 ZNF467 ZNF865 ZNF850 ZKSCAN5 ZNF546 ZNF77 ZNF490 ZNF16 ZSCAN5B ZNF20 ZNF182 PRDM9 ZNF100 ZNF660 ZNF334 ZNF43 ZNF540 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZFP62 | 1.49e-27 | 314 | 126 | 31 | PF13912 |
| Domain | SCAN_BOX | 4.44e-05 | 58 | 126 | 5 | PS50804 | |
| Domain | Nuc_orph_rcpt | 1.35e-04 | 3 | 126 | 2 | IPR003070 | |
| Domain | HMGI_Y | 2.69e-04 | 4 | 126 | 2 | PS00354 | |
| Domain | SCAN | 5.53e-04 | 56 | 126 | 4 | SM00431 | |
| Domain | SCAN | 6.32e-04 | 58 | 126 | 4 | PF02023 | |
| Domain | SCAN_dom | 6.32e-04 | 58 | 126 | 4 | IPR003309 | |
| Domain | Retrov_capsid_C | 6.75e-04 | 59 | 126 | 4 | IPR008916 | |
| Domain | AT_hook | 7.79e-04 | 27 | 126 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 7.79e-04 | 27 | 126 | 3 | IPR017956 | |
| Domain | SH3_9 | 1.92e-03 | 78 | 126 | 4 | PF14604 | |
| Domain | E3_UB_ligase_RBR | 1.96e-03 | 10 | 126 | 2 | IPR031127 | |
| Domain | MetalloPept_cat_dom | 2.20e-03 | 81 | 126 | 4 | IPR024079 | |
| Domain | - | 2.20e-03 | 81 | 126 | 4 | 3.40.390.10 | |
| Domain | Peptidase_M12B_N | 2.29e-03 | 39 | 126 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.29e-03 | 39 | 126 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 2.47e-03 | 40 | 126 | 3 | PS00427 | |
| Domain | Reprolysin | 2.47e-03 | 40 | 126 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 2.47e-03 | 40 | 126 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.47e-03 | 40 | 126 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 2.47e-03 | 40 | 126 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 2.65e-03 | 41 | 126 | 3 | IPR001762 | |
| Domain | EGF_CA | 2.74e-03 | 86 | 126 | 4 | PF07645 | |
| Domain | IBR | 3.90e-03 | 14 | 126 | 2 | SM00647 | |
| Domain | IBR | 3.90e-03 | 14 | 126 | 2 | PF01485 | |
| Domain | EGF_Ca-bd_CS | 4.22e-03 | 97 | 126 | 4 | IPR018097 | |
| Domain | ZINC_PROTEASE | 4.38e-03 | 98 | 126 | 4 | PS00142 | |
| Domain | IBR_dom | 4.48e-03 | 15 | 126 | 2 | IPR002867 | |
| Domain | EGF_CA | 4.54e-03 | 99 | 126 | 4 | PS01187 | |
| Domain | AT_hook | 5.09e-03 | 16 | 126 | 2 | PF02178 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | RAD51 ZNF793 ZNF671 ZNF585A ZNF354A ZNF154 ZNF337 ZNF460 ZFP30 NR4A3 NR4A1 ZFP69 ZKSCAN5 ZNF595 ZNF786 ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 KMT2C ZNF20 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF45 ZNF655 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF30 MNAT1 ZNF583 | 2.56e-16 | 1387 | 92 | 39 | M734 |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF585A ZNF354A ZFP30 NR4A3 NR4A1 ZFP69 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF585B ZNF490 ZNF394 ZNF43 ZNF45 ZNF655 ZNF347 ZNF624 ZNF420 MNAT1 ZNF583 | 1.60e-08 | 768 | 92 | 21 | MM14851 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ZNF585A ZNF354A ZFP30 NR4A3 NR4A1 ZFP69 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF585B ZNF490 ZNF394 ZNF43 ZNF45 ZNF655 ZNF347 ZNF624 ZNF420 MNAT1 ZNF583 | 1.91e-06 | 1022 | 92 | 21 | MM15436 |
| Pubmed | ZNF354A ZNF460 ZNF595 ZNF587B ZNF77 ZNF490 ZNF430 ZNF20 ZNF182 ZNF100 ZNF45 ZNF655 ZNF624 ZNF480 ZNF841 ZNF583 | 8.30e-18 | 181 | 128 | 16 | 37372979 | |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 1.07e-11 | 49 | 128 | 8 | 9630514 | |
| Pubmed | 1.75e-10 | 4 | 128 | 4 | 12860387 | ||
| Pubmed | Multiple genes encoding zinc finger domains are expressed in human T cells. | 1.51e-09 | 31 | 128 | 6 | 2288909 | |
| Pubmed | Specific and ubiquitous expression of different Zn finger protein genes in the mouse. | 6.07e-09 | 7 | 128 | 4 | 3143103 | |
| Pubmed | Cholinergic signals preserve haematopoietic stem cell quiescence during regenerative haematopoiesis. | 3.61e-08 | 10 | 128 | 4 | 35087060 | |
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 21239433 | ||
| Pubmed | A cholinergic neuroskeletal interface promotes bone formation during postnatal growth and exercise. | 5.66e-08 | 11 | 128 | 4 | 35276096 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 1.94e-07 | 4 | 128 | 3 | 19091768 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 4.84e-07 | 5 | 128 | 3 | 17855024 | |
| Pubmed | 8.10e-07 | 20 | 128 | 4 | 7479878 | ||
| Pubmed | 8.10e-07 | 20 | 128 | 4 | 2542606 | ||
| Pubmed | ZSCAN12 ZBTB17 PATZ1 LASP1 ZNF595 ZNF786 ABLIM1 ZSCAN5B ZNF394 ZNF334 ZNF43 ZNF655 ZFP41 ZNF347 | 1.80e-06 | 808 | 128 | 14 | 20412781 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZSCAN12 ZNF460 NR4A3 ZNF467 ZNF850 ZNF587B ZNF518A ZNF16 ABLIM1 GLG1 ZNF655 LRP1 ZNF70 ZNF420 ZNF319 ZFP62 TMEM167A | 2.15e-06 | 1203 | 128 | 17 | 29180619 |
| Pubmed | 5.73e-06 | 10 | 128 | 3 | 18162309 | ||
| Pubmed | 7.86e-06 | 11 | 128 | 3 | 32908007 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 38070724 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 34453977 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 26999808 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 27129924 | ||
| Pubmed | Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. | 1.34e-05 | 2 | 128 | 2 | 23521765 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 28258105 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19344760 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 29114104 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 33995108 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 32552811 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 24836856 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15948184 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 35678315 | ||
| Pubmed | Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. | 1.34e-05 | 2 | 128 | 2 | 12628457 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 25157794 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 31202708 | ||
| Pubmed | Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors. | 1.34e-05 | 2 | 128 | 2 | 22246862 | |
| Pubmed | The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of β-cell mass. | 1.34e-05 | 2 | 128 | 2 | 30696767 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 27471776 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22688057 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 32028688 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 30429582 | ||
| Pubmed | A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neurons. | 1.34e-05 | 2 | 128 | 2 | 21501254 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 21368056 | ||
| Pubmed | NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes. | 1.34e-05 | 2 | 128 | 2 | 28249906 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 1400473 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20668010 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 26937017 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 36603528 | ||
| Pubmed | Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production. | 1.34e-05 | 2 | 128 | 2 | 26650489 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22848433 | ||
| Pubmed | Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. | 1.34e-05 | 2 | 128 | 2 | 16650968 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 35413868 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 24462939 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 29261717 | ||
| Pubmed | Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. | 1.34e-05 | 2 | 128 | 2 | 18199426 | |
| Pubmed | Stroke-induced activation of the α7 nicotinic receptor increases Pseudomonas aeruginosa lung injury. | 1.34e-05 | 2 | 128 | 2 | 22490926 | |
| Pubmed | The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. | 1.34e-05 | 2 | 128 | 2 | 25410408 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23270857 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 18077004 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19462340 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 16923147 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11790782 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 37746145 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19631623 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15770102 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 24326163 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23811428 | ||
| Pubmed | Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells. | 1.34e-05 | 2 | 128 | 2 | 20720594 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17019565 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19100751 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 35883638 | ||
| Pubmed | Chrna7 genotype is linked with alpha7 nicotinic receptor expression but not alpha7 RNA levels. | 1.34e-05 | 2 | 128 | 2 | 19368846 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15009674 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 38253622 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 34514543 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22183893 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 9364063 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 12606407 | ||
| Pubmed | Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia. | 1.34e-05 | 2 | 128 | 2 | 22300029 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 32018068 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 26206074 | ||
| Pubmed | Nicotine elicits prolonged calcium signaling along ventral hippocampal axons. | 1.34e-05 | 2 | 128 | 2 | 24349346 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 21143250 | ||
| Pubmed | Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice. | 1.34e-05 | 2 | 128 | 2 | 16319313 | |
| Pubmed | Impaired synaptic plasticity in the visual cortex of mice lacking α7-nicotinic receptor subunit. | 1.34e-05 | 2 | 128 | 2 | 25797465 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 29197398 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 38178134 | ||
| Pubmed | Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. | 1.34e-05 | 2 | 128 | 2 | 17515897 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23325242 | ||
| Pubmed | Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors. | 1.34e-05 | 2 | 128 | 2 | 22649244 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17898229 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 21901321 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17935702 | ||
| Pubmed | Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice. | 1.34e-05 | 2 | 128 | 2 | 21205929 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 35908188 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20624304 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 21784975 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20659128 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20843956 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 10800961 | ||
| Pubmed | Characterization of allelic variants at chromosome 15q14 in schizophrenia. | 1.34e-05 | 2 | 128 | 2 | 16417613 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11834293 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22314319 | ||
| Interaction | NOTCH2 interactions | ZBTB17 ZNF460 PATZ1 SMOC1 ZNF865 ZNF587B ZNF518A ZNF490 CCN6 ZNF430 ZNF594 ADAMTS9 ZFP41 ADAMTS15 ZNF624 ZNF480 ZNF431 | 9.57e-10 | 423 | 124 | 17 | int:NOTCH2 |
| Interaction | ZNF467 interactions | ZNF354A PATZ1 ZFP30 ZNF467 ZNF587B RIOX2 ZNF16 ZNF100 ZNF624 ZNF480 ZFP62 | 1.41e-08 | 179 | 124 | 11 | int:ZNF467 |
| Interaction | LTBP2 interactions | 5.30e-08 | 85 | 124 | 8 | int:LTBP2 | |
| Interaction | FBLN5 interactions | 6.18e-07 | 159 | 124 | 9 | int:FBLN5 | |
| Interaction | TRIM28 interactions | ZNF354A ZNF460 ZFP30 HSPH1 NR4A3 LASP1 NR4A1 ZNF595 ZNF587B ZNF518A ZNF585B ZNF77 ZNF490 ZNF430 ZNF20 ZNF182 IARS2 ZNF100 ZNF45 ZNF655 ZNF624 ZNF480 ZNF420 ZNF841 ZNF30 ZNF583 | 8.56e-07 | 1474 | 124 | 26 | int:TRIM28 |
| Interaction | ANOS1 interactions | 2.95e-05 | 143 | 124 | 7 | int:ANOS1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF793 ZNF671 ZNF585A ZNF154 ZNF460 ZFP30 ZNF865 ZNF850 FBXO46 ZNF587B ZNF546 ZNF585B ZSCAN5B ZNF45 ZNF540 ZNF347 ZNF480 ZNF420 ZNF841 ZNF30 ZNF583 | 1.87e-11 | 1192 | 128 | 21 | chr19q13 |
| Cytoband | 19q13.12 | 1.41e-09 | 72 | 128 | 7 | 19q13.12 | |
| Cytoband | 22q11.21 | 2.74e-04 | 111 | 128 | 4 | 22q11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 3.93e-04 | 122 | 128 | 4 | chr19p12 | |
| Cytoband | 7q36.1 | 1.19e-03 | 74 | 128 | 3 | 7q36.1 | |
| Cytoband | 19q13.43 | 1.89e-03 | 87 | 128 | 3 | 19q13.43 | |
| Cytoband | 19p12 | 2.08e-03 | 90 | 128 | 3 | 19p12 | |
| Cytoband | 5q35.3 | 2.43e-03 | 95 | 128 | 3 | 5q35.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF449 ZNF793 ZNF671 ZSCAN12 ZNF585A ZNF354A ZBTB17 ZNF154 ZNF337 ZNF460 PATZ1 ZFP30 OSR2 ZNF467 ZFP69 ZNF865 ZNF850 ZKSCAN5 ZNF595 ZNF786 ZNF587B ZNF518A ZNF546 ZNF585B ZNF77 ZNF490 ZNF430 SP8 ZNF16 ZNF594 ZSCAN5B ZNF20 ZNF182 PRDM9 ZNF100 ZNF394 ZNF660 ZNF334 ZNF43 ZNF45 ZNF655 ZFP41 ZNF540 ZNF347 ZNF70 ZNF624 ZNF480 ZNF431 ZNF420 ZNF841 ZNF30 ZNF319 ZNF583 ZFP62 | 8.59e-49 | 718 | 101 | 54 | 28 |
| Coexpression | NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON | 8.43e-10 | 22 | 128 | 6 | M8692 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP | 3.26e-06 | 182 | 128 | 8 | M4255 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP | 5.85e-06 | 197 | 128 | 8 | M4257 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_CORTICAL_PLATE | 1.54e-05 | 31 | 128 | 4 | MM439 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ZSCAN12 ZNF354A RTEL1 ZFP30 HSPH1 TLR7 FAM171B ZFP69 GFRA2 CHRNA7 ZNF490 FZD8 SP8 IARS2 PRDM9 ZNF334 ZNF43 ZFP41 TLL1 PHF11 ZNF624 ZFP62 | 2.37e-05 | 1459 | 121 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ZSCAN12 ZNF354A RTEL1 ZFP30 HSPH1 TLR7 FAM171B ZFP69 GFRA2 CHRNA7 ZNF490 FZD8 IARS2 PRDM9 ZNF334 ZNF43 ZFP41 TLL1 ZNF624 ZFP62 | 2.76e-05 | 1257 | 121 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-06 | 197 | 128 | 7 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 171 | 128 | 6 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-05 | 182 | 128 | 6 | 1d37c486173cc4629842893ddd5033987c04086f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-05 | 182 | 128 | 6 | aef67bdc6937b315522d39959e26c9b0acf7ab52 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-05 | 182 | 128 | 6 | 087c9f88daf08f5d688b728c2386f91f210d2255 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-05 | 183 | 128 | 6 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-05 | 183 | 128 | 6 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-05 | 183 | 128 | 6 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_RCN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-05 | 185 | 128 | 6 | 538db481c82b02e5d3b8e03b166f754cc936901e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 186 | 128 | 6 | fef543f188edb0d1704d9c6ace366a0f8017bf53 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-05 | 110 | 128 | 5 | 0b39f3c358715e6e7288d3e4a0f3e7c0e877333c | |
| ToppCell | Endothelial-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.75e-05 | 188 | 128 | 6 | ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-05 | 189 | 128 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.80e-05 | 189 | 128 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.80e-05 | 189 | 128 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-05 | 193 | 128 | 6 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-05 | 193 | 128 | 6 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 193 | 128 | 6 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-05 | 193 | 128 | 6 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.27e-05 | 197 | 128 | 6 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-05 | 118 | 128 | 5 | 7e6cb77fa9154f2da985c455bb6a24d6029cc8d6 | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 2.34e-05 | 198 | 128 | 6 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 2.34e-05 | 198 | 128 | 6 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.41e-05 | 199 | 128 | 6 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 200 | 128 | 6 | c59f262b2b0a7e7dcb2940d1e466f98db6c56625 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 200 | 128 | 6 | e50ef394e3284a8323bfd60575b262b2be422aea | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.96e-05 | 124 | 128 | 5 | ff08f74c3bc8e60679e0e21370095936a174c580 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-C1ql1-Inhibitory_Neuron.Gad1Gad2_Pvalb.C1ql1_(Interneuron,_Chandelier)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.07e-05 | 62 | 128 | 4 | 13d05f73bc15fcfcf2aaa82b74b76753d4abc0ca | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-C1ql1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.07e-05 | 62 | 128 | 4 | 7372aff17fc18bd4fee0655254796e60f6b25d24 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-C1ql1-Inhibitory_Neuron.Gad1Gad2_Pvalb.C1ql1_(Interneuron,_Chandelier)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.07e-05 | 62 | 128 | 4 | 852a5e778f212b63b9216cd7048972eb35f343c8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.28e-05 | 140 | 128 | 5 | 72c272f44e5600b3037c1dbf9d3a4669a35588d8 | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|Endothelial_cells / Location, Cell class and cell subclass | 8.30e-05 | 154 | 128 | 5 | afdc385397c7b13c9348eeef95f109f2363057ae | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.37e-05 | 158 | 128 | 5 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 160 | 128 | 5 | 55f599df6e3b7a5a505df4b094c834281311d94a | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 160 | 128 | 5 | 296e53e1e0786346d38db2d4188b9a1c0430627b | |
| ToppCell | severe_influenza-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 9.94e-05 | 160 | 128 | 5 | a1181ef36b453eba53b04d836aa9f65a71354cdb | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 165 | 128 | 5 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 165 | 128 | 5 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | CV-Mild-6|CV / Virus stimulation, Condition and Cluster | 1.21e-04 | 167 | 128 | 5 | cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 168 | 128 | 5 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.25e-04 | 168 | 128 | 5 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 168 | 128 | 5 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 168 | 128 | 5 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-04 | 169 | 128 | 5 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 170 | 128 | 5 | 8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 170 | 128 | 5 | f5140eb9313c0d1bb31f8a761d9c062c56733a61 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 172 | 128 | 5 | 35e961c88bfe79046533396912cedf00ca81db7b | |
| ToppCell | Control-PLT_5|Control / Disease Group and Platelet Clusters | 1.39e-04 | 172 | 128 | 5 | 950d0a5b7908ee6ef8d30f123c9c7f7180dd4c26 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 172 | 128 | 5 | c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-04 | 172 | 128 | 5 | 48d0cfc37d1b1ae48ed8f8b2711abeb609d2bb6e | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 172 | 128 | 5 | 7c085c02b59e24e2a2cd393b5e692f9fb19257fe | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 177 | 128 | 5 | aa56129d2d5a73a10e33b7162233a4d9337ee535 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 177 | 128 | 5 | d78a6003ce2d15d7771ae385de252eec7e3c3eea | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-04 | 177 | 128 | 5 | 3a150dcaefa342d49968b42c7cdb1fbb633adcd0 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 177 | 128 | 5 | 70ca5b6fde2e38af1eb88a7d6e8746edba298191 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.59e-04 | 177 | 128 | 5 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 178 | 128 | 5 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 178 | 128 | 5 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 178 | 128 | 5 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 178 | 128 | 5 | 20d9433332b58270bca6807a6cf633971dbaa2b7 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-04 | 179 | 128 | 5 | 163f5430d72ea0c1b239ea5d21e53be536636d3d | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 179 | 128 | 5 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 179 | 128 | 5 | e7045e27f0eb88f552b31c04b56d78e5ccd7a36c | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-04 | 179 | 128 | 5 | 0624dd537a68736f4d7b8b4de2c56168ed0e60a9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 181 | 128 | 5 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 182 | 128 | 5 | f703963b5d1e8c1f95d78807521048553b0792d8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 182 | 128 | 5 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 182 | 128 | 5 | ebd177ad5eac51bf2db0657596618bdf1e5d46e1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.96e-04 | 185 | 128 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-04 | 185 | 128 | 5 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 185 | 128 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 185 | 128 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-04 | 185 | 128 | 5 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-04 | 186 | 128 | 5 | a558fd00053e7dd6216b01dc8e650c30cee451f1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-04 | 186 | 128 | 5 | 75b1f342be5d6dbe0e7acd924a0ca75964f6bab0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-04 | 186 | 128 | 5 | 0c3d195077de7b4c354c127a26116438aef29244 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 2.01e-04 | 186 | 128 | 5 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 187 | 128 | 5 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 187 | 128 | 5 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 187 | 128 | 5 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.11e-04 | 188 | 128 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-04 | 188 | 128 | 5 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-04 | 188 | 128 | 5 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-04 | 188 | 128 | 5 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.21e-04 | 190 | 128 | 5 | 8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.21e-04 | 190 | 128 | 5 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-04 | 190 | 128 | 5 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 2.21e-04 | 190 | 128 | 5 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.22e-04 | 103 | 128 | 4 | 780a94c27ac3eb138a9f284251ae094d3e97ce71 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 191 | 128 | 5 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 191 | 128 | 5 | 631f95fd80dd3678b5b2ef201abf7fe646049af6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 191 | 128 | 5 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 2.32e-04 | 192 | 128 | 5 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-04 | 192 | 128 | 5 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-04 | 192 | 128 | 5 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 2.38e-04 | 193 | 128 | 5 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.38e-04 | 193 | 128 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 193 | 128 | 5 | 9c2f58b4c89dc084a1a6e53952ea793e87a96660 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.38e-04 | 193 | 128 | 5 | 09de51f8ac509e03d480ed3dc9dfe7e7defc59cb | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.38e-04 | 193 | 128 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| Disease | Keratosis pilaris decalvans | 4.43e-05 | 3 | 114 | 2 | C0343057 | |
| Disease | hormone measurement, testosterone measurement | 4.43e-05 | 3 | 114 | 2 | EFO_0004730, EFO_0004908 | |
| Disease | hormone measurement, progesterone measurement | 1.47e-04 | 5 | 114 | 2 | EFO_0004730, EFO_0007004 | |
| Disease | hormone measurement, dehydroepiandrosterone sulphate measurement | 1.47e-04 | 5 | 114 | 2 | EFO_0004730, EFO_0007001 | |
| Disease | cognitive disorder (implicated_via_orthology) | 2.20e-04 | 6 | 114 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 2.20e-04 | 6 | 114 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | androsterone sulfate measurement | 2.82e-04 | 33 | 114 | 3 | EFO_0021117 | |
| Disease | chronic kidney disease (implicated_via_orthology) | 9.52e-04 | 12 | 114 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 9.52e-04 | 12 | 114 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Diabetic Asymmetric Polyneuropathy | 1.31e-03 | 14 | 114 | 2 | C0393835 | |
| Disease | Diabetic Neuralgia | 1.31e-03 | 14 | 114 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 1.31e-03 | 14 | 114 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 1.31e-03 | 14 | 114 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 1.31e-03 | 14 | 114 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 1.31e-03 | 14 | 114 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 1.31e-03 | 14 | 114 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 1.31e-03 | 14 | 114 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 1.31e-03 | 14 | 114 | 2 | C0271680 | |
| Disease | Insulin Sensitivity | 1.64e-03 | 60 | 114 | 3 | C0920563 | |
| Disease | Insulin Resistance | 1.64e-03 | 60 | 114 | 3 | C0021655 | |
| Disease | X-21410 measurement | 1.71e-03 | 16 | 114 | 2 | EFO_0800813 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.88e-03 | 63 | 114 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | phospholipid measurement | 2.16e-03 | 140 | 114 | 4 | EFO_0004639 | |
| Disease | dehydroepiandrosterone sulphate measurement | 2.34e-03 | 68 | 114 | 3 | EFO_0007001 | |
| Disease | Major Depressive Disorder | 2.58e-03 | 243 | 114 | 5 | C1269683 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 3.25e-03 | 22 | 114 | 2 | EFO_0021115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CPSDRKVEGCYAKAR | 161 | P19397 | |
| DECASGKVICPYNRR | 176 | Q8IUX8 | |
| KDYCPRGRVCNSVDP | 66 | O14639 | |
| FLPCEEKDVRCGKIY | 546 | Q9H2U9 | |
| VARGLKPAVLYDCNC | 46 | Q96LT6 | |
| RGKFKEICERPNGSC | 21 | Q8NET1 | |
| EGVRVKYRSCNLEPC | 556 | Q8TE58 | |
| IPGKRSERFYECCKE | 201 | P36544 | |
| RGETRICKIYDSPCL | 306 | Q06609 | |
| LRRAGCPYQADEKVK | 401 | A6NNM3 | |
| LRRAGCPYQADEKVK | 401 | A6NJZ7 | |
| PNICEYLTRESKCRV | 2166 | Q14571 | |
| YICLANKDCPVDKRR | 301 | P22736 | |
| KQCPVCRVYIERNEG | 191 | Q7Z419 | |
| LGCKPYLDSQRAACR | 166 | Q9BZM1 | |
| RCKQLICDPSYVKDR | 276 | P50395 | |
| CRYLCSIEEKDGRPV | 4596 | Q8NEZ4 | |
| RKLRTPAKCRECNSY | 706 | Q92619 | |
| MDDQGCPRCKTTKYR | 1 | P51948 | |
| AYQKCRQPDCGAEIL | 176 | A6NDA9 | |
| REEQKRRECGYSCSP | 436 | Q9NS40 | |
| KRLCEQVREAACAPY | 56 | Q5JYT7 | |
| RCQPRYTGDKCELDQ | 4221 | Q07954 | |
| RDKLCGPYEKFICEQ | 646 | Q92598 | |
| ARCGKIVYPTEKVNC | 6 | Q14847 | |
| TPNYCKGTCLRVLRD | 316 | O95972 | |
| RRAVCCDVVYKLPFG | 2936 | Q9Y6V0 | |
| RDPLYRDDPCKQCRK | 521 | Q6PJ61 | |
| SKKPQYLDTCIRCGE | 311 | Q6ZV70 | |
| AECRRKGIPQAVYCK | 51 | Q9BYS8 | |
| PDLCAVYAVQVRCKR | 601 | P48357 | |
| YETRCKEARPVKNGC | 191 | P20783 | |
| IKPYSCEQCGKVFRR | 281 | Q8N2R0 | |
| PETCYQRLKKRCREE | 186 | O00142 | |
| IPGKRSERFYECCKE | 111 | Q494W8 | |
| GQKKCTCYRPNRRET | 121 | O60243 | |
| YKVPVLGCVDRQSCR | 26 | O95867 | |
| PKCKVYIERDEGCAQ | 186 | P50876 | |
| SGNCPKDRYVVCGRV | 606 | Q8NB91 | |
| DKVPCQVCGKYLRAA | 466 | Q9HBE1 | |
| KPYVCRECGRGFRDK | 746 | Q9NQV7 | |
| RKEKRLCYIQPCDSN | 241 | O95389 | |
| CERAKAGCAPLMRQY | 111 | Q9H461 | |
| PVLYRKCQGDASRLC | 561 | Q92896 | |
| PEERKTCRNVYNCEL | 1721 | Q9P2N4 | |
| QESPLYDCRCKRGMK | 86 | O00451 | |
| PVRAYKRLDGSTECC | 321 | O43462 | |
| CARIGERKSPYVAVC | 46 | Q8TBQ9 | |
| CRTNKKCSRGYEPNE | 586 | Q9NQ79 | |
| VPDYKQLRQCRKEVC | 1286 | Q9NYC9 | |
| RDYCSLCDKQPIGRL | 51 | P34947 | |
| CALPGCKFKDVRRNV | 46 | Q16667 | |
| CYCRDKCGTPQKRER | 376 | Q6P995 | |
| PELCIKTGACRVEYK | 361 | Q6ZQY2 | |
| GCKEKVLRNPYREEC | 156 | Q8N9Y4 | |
| VRVEYRCPECAKVFS | 291 | Q01101 | |
| YVCLANKNCPVDKRR | 326 | Q92570 | |
| YRPKVCVLGSREQLC | 131 | Q9NZ71 | |
| DIAQARKLYRCPACG | 336 | O43897 | |
| RKLYRCPACGETLQE | 341 | O43897 | |
| LRRAGCPYQADEKVK | 401 | Q9UFD9 | |
| PRDDLYGAIKKLCCV | 676 | Q8TC59 | |
| KRKRSSGACRYCDPD | 51 | Q8NEA9 | |
| LYCEKENDPKRRSCQ | 806 | Q9NSE4 | |
| CYNRFVPCKNGIRKC | 116 | P60153 | |
| DRPTPYKCGIRSCQK | 236 | Q86UD1 | |
| TGEKRFACPVCNKRF | 411 | Q8IXZ3 | |
| RKCCAQYPKGRSVVC | 36 | P56277 | |
| RQKPRECQEYGKTLC | 116 | P17039 | |
| MCEYQRAKCRDPTLG | 66 | Q9H4F8 | |
| KPYRCEECGKAFNRS | 286 | Q8TF32 | |
| EKPYRCEECGKAFNR | 286 | Q8IYN0 | |
| RPYKCEECGKAFRTN | 806 | Q9P2J8 | |
| PYKCKECGKAFRQSR | 311 | Q8IYB9 | |
| YSLDGDCRPNLKRIC | 266 | Q5GJ75 | |
| PYECKECGKTFRVRS | 466 | Q8NDQ6 | |
| DVKPYKCVRCGKTFR | 491 | Q8NDQ6 | |
| ERPYRCRECGKSFSQ | 336 | Q6ZN11 | |
| RIKNGEKPFECTACR | 226 | P17025 | |
| GERPYECKQCGKTFR | 516 | Q15935 | |
| PYVCSECGREFIRKQ | 506 | Q8TAW3 | |
| YECVECGKAFNRRSP | 476 | Q14592 | |
| EKPYTCLKCGERFRQ | 411 | Q53GI3 | |
| TRERPYKCELCGKVF | 601 | P0CJ78 | |
| EKPYECRQCGKAFRC | 336 | P17024 | |
| FQRKKPYECSECGRI | 81 | Q8N8Y5 | |
| KPYECGECGKAFRVR | 156 | Q9Y2G7 | |
| PYECKECGKAFRVRG | 241 | Q9Y2G7 | |
| GEKPYVCSDCRKTFR | 261 | Q9HCZ1 | |
| TREKPYECKQCGRVF | 441 | Q9ULM2 | |
| TGERPYMCDVCQKRF | 406 | A6NJL1 | |
| KPYECDECGKTFILR | 216 | Q6AZW8 | |
| PYECKVCGKTFRVQR | 356 | Q86UE3 | |
| KPYVCTECGRAFIRK | 576 | Q52M93 | |
| VDRPCARAVKVDCPY | 921 | O15040 | |
| NCKRKCRDSYQEPPR | 1276 | Q6AHZ1 | |
| EKRTCALCPKDVEYN | 41 | Q9UIL8 | |
| AKIKGYQRLISPDCC | 876 | Q9NYK1 | |
| YGRDVNVCRCVNGKK | 96 | Q8IUF8 | |
| KPYVCTECGRAFIRK | 576 | Q6P3V2 | |
| VCRCRAGTQPLDSYK | 106 | P43489 | |
| KRINTGEKPYTCEEC | 221 | P17038 | |
| KPYKCNECGKAFRAR | 371 | Q96SE7 | |
| TRGKPYQCDVCGRIF | 196 | Q6ZN19 | |
| RPYKCNECGKVFNRI | 481 | Q8WV37 | |
| ERPYKCGECEKSFSR | 351 | E7ETH6 | |
| FQCPECDKRYRVKAD | 621 | Q8N393 | |
| EKPYRCEECGKTFNR | 286 | Q9H8G1 | |
| RCGECQKAFKRPSDL | 316 | Q9P2F9 | |
| REKPYTCSECGKDFR | 376 | Q8N720 | |
| KPYVCERCGKRFVQS | 556 | Q13105 | |
| KRPYECRECGKDFSR | 221 | Q9UC06 | |
| ERPYVCDVCGKTFRN | 446 | Q8NB50 | |
| EKPYVCSECGKAFRR | 346 | P17020 | |
| GEKPYECRECRKAFT | 611 | Q8TAQ5 | |
| KPYQCTECGKAFRRR | 486 | Q96JF6 | |
| EKPYECRECGKSFRQ | 186 | Q13106 | |
| ERPYKCNECGKTFRC | 491 | O60765 | |
| RKPCSDDYRKRVGSC | 21 | Q2TAA8 | |
| KPYQCDECGKAFRQR | 551 | O43309 | |
| DREKRDSVCPQGKYI | 36 | P19438 | |
| EKPYRCDVCGKRFRQ | 581 | Q02386 | |
| KDQCPYSGCKEALIR | 56 | Q96H15 | |
| GERPYECKECRKAFS | 376 | Q96ND8 | |
| GERPYECKDCRKSFR | 516 | Q96ND8 | |
| CRGPLAERQKFCFKV | 261 | Q8NFA0 | |
| KPYECPDCGKAFRQR | 671 | A8MQ14 | |
| ERPYECTVCKKRFTR | 376 | Q6P9G9 | |
| ERPYPCAECGKRFSQ | 241 | Q7Z7K2 | |
| PFRCEECGKSYNQRV | 576 | Q9Y2L8 | |
| RPYECQECGRKFSNK | 711 | Q9Y3M9 | |
| EKPFRCKECGRAFSQ | 296 | Q49AA0 |